Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of peptides interfering with the LRRK2/PP1 interaction.
Dong CZ, Bruzzoni-Giovanelli H, Yu Y, Dorgham K, Parizot C, Zini JM, Brossas JY, Tuffery P, Rebollo A. Dong CZ, et al. Among authors: zini jm. PLoS One. 2020 Aug 13;15(8):e0237110. doi: 10.1371/journal.pone.0237110. eCollection 2020. PLoS One. 2020. PMID: 32790695 Free PMC article.
Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.
Soussain C, Hoang-Xuan K, Taillandier L, Fourme E, Choquet S, Witz F, Casasnovas O, Dupriez B, Souleau B, Taksin AL, Gisselbrecht C, Jaccard A, Omuro A, Sanson M, Janvier M, Kolb B, Zini JM, Leblond V; Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire. Soussain C, et al. Among authors: zini jm. J Clin Oncol. 2008 May 20;26(15):2512-8. doi: 10.1200/JCO.2007.13.5533. Epub 2008 Apr 14. J Clin Oncol. 2008. PMID: 18413641 Clinical Trial.
Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: the French intergroup experience.
Fornecker LM, Aurran-Schleinitz T, Michallet AS, Cazin B, Guieze R, Dilhuydy MS, Zini JM, Tomowiak C, Lepretre S, Cymbalista F, Brion A, Feugier P, Delmer A, Leblond V, Ysebaert L. Fornecker LM, et al. Among authors: zini jm. Am J Hematol. 2015 Jun;90(6):511-4. doi: 10.1002/ajh.23999. Epub 2015 Apr 1. Am J Hematol. 2015. PMID: 25752923 Free article. Clinical Trial.
Prevalence, distribution and predictive value of XPO1 mutation in a real-life chronic lymphocytic leukaemia cohort.
Tueur G, Lazarian G, Eclache V, Fleury C, Letestu R, Lévy V, Lefebvre V, Collon JF, Zini JM, Thieblemont C, Soussi T, Cymbalista F, Baran-Marszak F. Tueur G, et al. Among authors: zini jm. Br J Haematol. 2020 Nov;191(3):e90-e94. doi: 10.1111/bjh.17046. Epub 2020 Aug 13. Br J Haematol. 2020. PMID: 32790071 Free article. No abstract available.
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib.
Ghez D, Calleja A, Protin C, Baron M, Ledoux MP, Damaj G, Dupont M, Dreyfus B, Ferrant E, Herbaux C, Laribi K, Le Calloch R, Malphettes M, Paul F, Souchet L, Truchan-Graczyk M, Delavigne K, Dartigeas C, Ysebaert L; French Innovative Leukemia Organization (FILO) CLL group. Ghez D, et al. Blood. 2018 Apr 26;131(17):1955-1959. doi: 10.1182/blood-2017-11-818286. Epub 2018 Feb 1. Blood. 2018. PMID: 29437588 Free article. Clinical Trial.
Results of three courses of adriamycin, bleomycin, vindesine, and dacarbazine with subtotal nodal irradiation in 189 patients with nodal Hodgkin's disease (stage I, II and IIIA).
André M, Brice P, Cazals D, Hennequin C, Fermé C, Kerneis Y, Rousselot P, Zini JM, Lepage E, Gisselbrecht C. André M, et al. Among authors: zini jm. Hematol Cell Ther. 1997 Apr;39(2):59-65. doi: 10.1007/s00282-997-0059-7. Hematol Cell Ther. 1997. PMID: 9168301 Clinical Trial.
54 results